Arrange a consultation about stem cells
Learn more
Get in touch with us today!
Would you like to find out more about our services? Fill out the form below and we will contact you as soon as possible to provide you with all the necessary information and answer your questions.
List of uses for stem cells approved by the FamiCord Group’s laboratories:
List of uses for stem cells approved by the FamiCord Group’s laboratories:
Nr.
Source
Source type
Diagnosis
Medical sector
Year of application
Therapy
Country
Age of the recipient
6301
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
62
6302
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
65
6303
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
62
6304
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
64
6305
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
63
6306
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
55
6307
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
60
6308
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
61
6309
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
62
6310
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
64
6311
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
55
6312
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
65
6313
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
64
6314
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
52
6315
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
61
6316
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
69
6317
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
73
6318
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
42
6319
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
60
6320
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
65
6321
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
66
6322
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
66
6323
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
65
6324
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
51
6325
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
69
6326
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
50
6327
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
67
6328
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
50
6329
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
64
6330
Apheresis
Autologous
Multiple Myeloma
Hematology
2018
Standard Therapy
Germany
56
6331
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
74
6332
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
67
6333
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
72
6334
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
59
6335
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
50
6336
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
62
6337
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
68
6338
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
54
6339
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
67
6340
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
22
6341
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
64
6342
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
77
6343
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
66
6344
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
60
6345
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
68
6346
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
39
6347
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
62
6348
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
56
6349
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
63
6350
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
63
6351
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
27
6352
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
70
6353
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
39
6354
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
71
6355
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
32
6356
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
59
6357
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
59
6358
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
63
6359
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
67
6360
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
65
6361
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
66
6362
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
48
6363
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
60
6364
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
57
6365
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
46
6366
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
49
6367
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
4
6368
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
67
6369
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
69
6370
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
63
6371
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
8
6372
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
58
6373
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
61
6374
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Poland
67
6375
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Germany
61
6376
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Germany
65
6377
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Germany
57
6378
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2018
Standard Therapy
Germany
27
6379
Apheresis
Allogeneic
Myelodysplastic Syndrome – Raeb
Hematology
2018
Standard Therapy
Poland
61
6380
Apheresis
Allogeneic
Myelodysplastic Syndrome Refractory Anemia With Blast Proliferation Ii
Hematology
2018
Standard Therapy
Germany
57
6381
Apheresis
Allogeneic
Myelodysplastic Syndrome; Acute Lymphoblastic Leukemia
Hematology
2018
Standard Therapy
Germany
65
6382
Apheresis
Allogeneic
Myelodysplastic Syndrome; Acute Myelogenous Leukemia
Hematology
2018
Standard Therapy
Poland
74
6383
Apheresis
Allogeneic
Myelodysplastic Syndrome; Myeloproliferative Neoplasms
Hematology
2018
Standard Therapy
Germany
62
6384
Apheresis
Allogeneic
Myelofibrosis
Hematology
2018
Standard Therapy
Poland
49
6385
Apheresis
Allogeneic
Myelofibrosis
Hematology
2018
Standard Therapy
Poland
60
6386
Apheresis
Allogeneic
Myelofibrosis
Hematology
2018
Standard Therapy
Poland
56
6387
Apheresis
Allogeneic
Myelofibrosis
Hematology
2018
Standard Therapy
Poland
58
6388
Apheresis
Allogeneic
Myelofibrosis
Hematology
2018
Standard Therapy
Poland
64
6389
Apheresis
Allogeneic
Myelofibrosis
Hematology
2018
Standard Therapy
Poland
68
6390
Apheresis
Allogeneic
Myelofibrosis
Hematology
2018
Standard Therapy
Poland
72
6391
Apheresis
Allogeneic
Myelofibrosis
Hematology
2018
Standard Therapy
Poland
53
6392
Apheresis
Allogeneic
Myeloma Multiplex
Hematology
2018
Standard Therapy
Poland
56
6393
Apheresis
Allogeneic
Myeloma Multiplex
Hematology
2018
Standard Therapy
Poland
57
6394
Apheresis
Allogeneic
Myeloma Multiplex
Hematology
2018
Standard Therapy
Poland
55
6395
Apheresis
Allogeneic
Myeloma Multiplex
Hematology
2018
Standard Therapy
Poland
52
6396
Apheresis
Allogeneic
Myeloproliferative Neoplasms
Hematology
2018
Standard Therapy
Poland
61
6397
Apheresis
Allogeneic
No Data
Hematology
2018
Standard Therapy
Poland
69
6398
Apheresis
Allogeneic
No Data
Hematology
2018
Standard Therapy
Poland
70
6399
Apheresis
Allogeneic
No Data
Hematology
2018
Standard Therapy
Poland
38
6400
Apheresis
Allogeneic
No Data
Hematology
2018
Standard Therapy
Poland
22